# Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease

> **NCT01066442** · PHASE3 · COMPLETED · sponsor: **Bioprojet** · enrollment: 273 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** BF2.649 (Pitolisant)

## Key facts

- **NCT ID:** NCT01066442
- **Lead sponsor:** Bioprojet
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2013-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01066442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01066442, "Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01066442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*